JAGX Stock Soars Over 10% Premarket After Best Day In Over 8 Years: What’s Driving The Surge?

Shares of Jaguar Health (JAGX) soared 11% in premarket trading on Wednesday following their best session in over eight years as FDA fee waivers for two drugs and a surge in retail interest put the commercial-stage pharmaceutical company’s rare-disease plans in focus.JAGX stock closed Tuesday at $34…